dronabinol has been researched along with Depression, Involutional in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Bara, A; Brennand, K; Callens, JE; Ellis, RJ; Frick, AL; Hurd, YL; Landry, J; Loh, E; Martin, Q; Rajarajan, P; Ramakrishnan, A; Shen, L; Szutorisz, H; Uzamere, TO; Vargas, CA | 1 |
| He, X; Huang, R; Wang, M; Wang, S; Yang, L; Zhu, R; Zhuang, X | 1 |
| Binswanger, I; Nussbaum, A; Thurstone, C | 1 |
| Agosti, V; Bisaga, A; Brooks, DJ; Carpenter, KM; Levin, FR; Mariani, J; Nunes, EV; Pavlicova, M; Sullivan, MA | 1 |
| Anghelescu, I; Jockers-Scherubl, M; Regen, F; Schindler, F | 1 |
| Koethe, D; Leweke, FM | 1 |
1 review(s) available for dronabinol and Depression, Involutional
| Article | Year |
|---|---|
Cannabis and psychiatric disorders: it is not only addiction.
Topics: Affect; Animals; Antipsychotic Agents; Anxiety Disorders; Bipolar Disorder; Brain; Cannabinoid Receptor Modulators; Cannabinoids; Cognition Disorders; Depressive Disorder, Major; Dronabinol; Drug Interactions; Humans; Marijuana Abuse; Mood Disorders; Psychoses, Substance-Induced; Receptor, Cannabinoid, CB1; Risk Factors; Schizophrenia; Signal Transduction | 2008 |
1 trial(s) available for dronabinol and Depression, Involutional
| Article | Year |
|---|---|
A randomized double-blind, placebo-controlled trial of venlafaxine-extended release for co-occurring cannabis dependence and depressive disorders.
Topics: Adult; Antidepressive Agents, Second-Generation; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Double-Blind Method; Dronabinol; Female; Humans; Male; Marijuana Abuse; Medication Adherence; Recurrence; Selective Serotonin Reuptake Inhibitors; Treatment Failure; Venlafaxine Hydrochloride | 2013 |
4 other study(ies) available for dronabinol and Depression, Involutional
| Article | Year |
|---|---|
Prenatal Δ
Topics: Animals; Cannabis; Depressive Disorder, Major; Dronabinol; Epigenesis, Genetic; Female; Male; Motivation; Nucleus Accumbens; Pregnancy; Rats | 2022 |
Targeting the Endocannabinoid/CB1 Receptor System For Treating Major Depression Through Antidepressant Activities of Curcumin and Dexanabinol-Loaded Solid Lipid Nanoparticles.
Topics: Animals; Antidepressive Agents; Apoptosis; Behavior, Animal; Corticosterone; Curcumin; Depressive Disorder, Major; Disease Models, Animal; Dopamine; Dronabinol; Drug Carriers; Lipids; MAP Kinase Kinase 1; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Nanoparticles; PC12 Cells; Rats; Receptor, Cannabinoid, CB1 | 2017 |
Medical marijuana use and suicide attempt in a patient with major depressive disorder.
Topics: Adult; Chronic Disease; Colorado; Depressive Disorder, Major; Dronabinol; Drug and Narcotic Control; Drug Approval; Ethylene Glycol; Female; Humans; Marijuana Abuse; Marijuana Smoking; Pain; Prescription Drugs; Risk Factors; Suicide, Attempted | 2011 |
Improvement in refractory obsessive compulsive disorder with dronabinol.
Topics: Adult; Cannabinoids; Comorbidity; Depressive Disorder, Major; Dronabinol; Drug Resistance; Female; Humans; Male; Obsessive-Compulsive Disorder; Psychotropic Drugs; Schizophrenia; Treatment Outcome | 2008 |